Cargando…

Age-Related Macular Degeneration: New Insights in Diagnosis, Treatment, and Prevention

Detalles Bibliográficos
Autores principales:	Mathis, Thibaud, Kodjikian, Laurent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878711/ https://www.ncbi.nlm.nih.gov/pubmed/35207337 http://dx.doi.org/10.3390/jcm11041064

Ejemplares similares

Relevance of Visual Acuity Measurement for Therapeutic Decisions in Age-Related Macular Degeneration
por: Mathis, Thibaud, et al.
Publicado: (2023)

Real-World Experience with Brolucizumab in Wet Age-Related Macular Degeneration: The REBA Study
por: Bilgic, Alper, et al.
Publicado: (2021)

Editorial: New insight into the diagnosis and treatment of age-related macular degeneration
por: Servillo, Andrea, et al.
Publicado: (2022)

Retinal Vascularization Analysis on Optical Coherence Tomography Angiography before and after Intraretinal or Subretinal Fluid Resorption in Exudative Age-Related Macular Degeneration: A Pilot Study
por: Mathis, Thibaud, et al.
Publicado: (2021)

Pharmacological Management of Diabetic Macular Edema in Real-Life Observational Studies
por: Kodjikian, Laurent, et al.
Publicado: (2018)

Characterisation of macular neovascularisation subtypes in age-related macular degeneration to optimise treatment outcomes
por: Mathis, Thibaud, et al.
Publicado: (2022)

Pharmacotherapy for Age-Related Macular Degeneration
por: Ahmadieh, Hamid
Publicado: (2008)

Efficacy and safety of intravitreal aflibercept in ranibizumab-refractory patients with neovascular age-related macular degeneration
por: Razavi, Sam, et al.
Publicado: (2021)

Age-Related Macular Degeneration and Diabetic Retinopathy
por: Ebneter, Andreas, et al.
Publicado: (2022)

Research Advances in Age-Related Macular Degeneration
por: Abdolrahimzadeh, Solmaz
Publicado: (2022)

Prevention of age-related macular degeneration
por: Wong, Ian Yat Hin, et al.
Publicado: (2010)

Nutlin-3a for age-related macular degeneration
por: Chung, Hyewon, et al.
Publicado: (2022)

Real-Life Value of the Odysight(®) Application in At-Home Screening for Exudative Recurrence of Macular Edema
por: Kielwasser, Gauthier, et al.
Publicado: (2022)

Impact of intravitreal aflibercept dosing regimens in treatment-naïve patients with neovascular age-related macular degeneration: 2-year results of RAINBOW
por: Weber, Michel, et al.
Publicado: (2020)

Age-Related Macular Degeneration: Epidemiology, Pathophysiology, Diagnosis, and Treatment
por: Vyawahare, Hrishikesh, et al.
Publicado: (2022)

Age-Related Macular Degeneration (AMD): A View to the Future
por: Miller, Joan W., et al.
Publicado: (2021)

Prevention of the Onset of Age-Related Macular Degeneration
por: Di Carlo, Emiliano, et al.
Publicado: (2021)

Bevacizumab and ranibizumab for neovascular age-related macular degeneration: an updated meta-analysis of randomised clinical trials
por: Kodjikian, Laurent, et al.
Publicado: (2014)

Age-Related Macular Degeneration: Insights into Inflammatory Genes
por: Cascella, Raffaella, et al.
Publicado: (2014)

Impact of Prophylactic Ranibizumab to Prevent Neovascular Age-Related Macular Degeneration on Eyes With Intermediate Age-Related Macular Degeneration
por: Chan, Clement K., et al.
Publicado: (2023)

Age-Related Macular Degeneration: Advances in Management and Diagnosis
por: Yonekawa, Yoshihiro, et al.
Publicado: (2015)

Federated learning for diagnosis of age-related macular degeneration
por: Gholami, Sina, et al.
Publicado: (2023)

New developments in age-related macular degeneration
por: da Cruz, Lyndon
Publicado: (2008)

Age Macular Degeneration: Etiology, Prevention, Individualized Therapies, Cell Therapy, and Tissue Engineering
por: García-Layana, Alfredo, et al.
Publicado: (2014)

Early Detection and Prevention of Age-Related Macular Degeneration
por: Seluarize, Gayathri, et al.
Publicado: (2023)

Impact of intravitreal aflibercept dosing regimens in treatment-naïve patients with neovascular age-related macular degeneration in routine clinical practice in France: results from the RAINBOW study
por: Weber, Michel, et al.
Publicado: (2020)

Age-related macular degeneration: current treatments
por: Hubschman, Jean Pierre, et al.
Publicado: (2009)

Aflibercept for the Treatment of Age-Related Macular Degeneration
por: Trichonas, George, et al.
Publicado: (2013)

Real-World Efficacy and Safety of Fluocinolone Acetonide Implant for Diabetic Macular Edema: A Systematic Review
por: Kodjikian, Laurent, et al.
Publicado: (2021)

Targeted Gene Candidates for Treatment and Early Diagnosis of Age-Related Macular Degeneration
por: Cinici, Emine, et al.
Publicado: (2021)

Age-related macular degeneration.
por: McConnell, V., et al.
Publicado: (2005)

Age-related macular degeneration
por: Querques, Giuseppe, et al.
Publicado: (2011)

Age-related macular degeneration
por: Mathenge, Wanjiku
Publicado: (2014)

Age-Related Macular Degeneration: New Paradigms for Treatment and Management of AMD
por: Hernández-Zimbrón, Luis Fernando, et al.
Publicado: (2018)

Relevance of Visual Acuity Measurement for Therapeutic Decisions in Diabetic Macular Edema
por: Mathis, Thibaud, et al.
Publicado: (2023)

Final 4-year results of the RAINBOW real-world study: intravitreal aflibercept dosing regimens in France in treatment-naïve patients with neovascular age-related macular degeneration
por: Cohen, Salomon-Yves, et al.
Publicado: (2022)

Macrophages and Macular Degeneration
por: Jager, Martine J.
Publicado: (2014)

Current Treatments and Innovations in Diabetic Retinopathy and Diabetic Macular Edema
por: Gonzalez-Cortes, Jesus H., et al.
Publicado: (2022)

Predictive, preventive and personalised medicine for age-related macular degeneration
por: Hasler, Pascal W., et al.
Publicado: (2010)

The Role of Dysregulated miRNAs in the Pathogenesis, Diagnosis and Treatment of Age-Related Macular Degeneration
por: Urbańska, Karolina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_70uo9ugggaipskvd8jbfedbjn5